These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26652110)

  • 1. Use of quantitative pharmacology tools to improve malaria treatments.
    Davis TM; Moore BR; Salman S; Page-Sharp M; Batty KT; Manning L
    Expert Rev Clin Pharmacol; 2016; 9(2):303-16. PubMed ID: 26652110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combined antimalarial therapy using artemisinin].
    Majori G
    Parassitologia; 2004 Jun; 46(1-2):85-7. PubMed ID: 15305693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment regimens for pregnant women with falciparum malaria.
    Moore BR; Salman S; Davis TM
    Expert Rev Anti Infect Ther; 2016 Aug; 14(8):691-704. PubMed ID: 27322015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modelling the time course of antimalarial parasite killing: a tour of animal and human models, translation and challenges.
    Patel K; Simpson JA; Batty KT; Zaloumis S; Kirkpatrick CM
    Br J Clin Pharmacol; 2015 Jan; 79(1):97-107. PubMed ID: 24251882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacology of artemisinin-based combination therapies.
    German PI; Aweeka FT
    Clin Pharmacokinet; 2008; 47(2):91-102. PubMed ID: 18193915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Split dosing of artemisinins does not improve antimalarial therapeutic efficacy.
    White NJ; Watson J; Ashley EA
    Sci Rep; 2017 Sep; 7(1):12132. PubMed ID: 28935919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetic evaluation of artemisinin drugs for the treatment of malaria in paediatric populations.
    Mercer AE; Sarr Sallah M
    Expert Opin Drug Metab Toxicol; 2011 Apr; 7(4):427-39. PubMed ID: 21320023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Semi-mechanistic pharmacokinetic/pharmacodynamic modelling of the antimalarial effect of artemisinin.
    Gordi T; Xie R; Jusko WJ
    Br J Clin Pharmacol; 2005 Dec; 60(6):594-604. PubMed ID: 16305583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cysteamine, the molecule used to treat cystinosis, potentiates the antimalarial efficacy of artemisinin.
    Min-Oo G; Fortin A; Poulin JF; Gros P
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3262-70. PubMed ID: 20479197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling Prevention of Malaria and Selection of Drug Resistance with Different Dosing Schedules of Dihydroartemisinin-Piperaquine Preventive Therapy during Pregnancy in Uganda.
    Wallender E; Zhang N; Conrad M; Kakuru A; Muhindo M; Tumwebaze P; Kajubi R; Mota D; Legac J; Jagannathan P; Havlir D; Kamya M; Dorsey G; Aweeka F; Rosenthal PJ; Savic RM
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30530597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and toxicological profile of artemisinin compounds: an update.
    Medhi B; Patyar S; Rao RS; Byrav D S P; Prakash A
    Pharmacology; 2009; 84(6):323-32. PubMed ID: 19851082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How artemisinin-containing combination therapies slow the spread of antimalarial drug resistance.
    Hastings I
    Trends Parasitol; 2011 Feb; 27(2):67-72. PubMed ID: 20971040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of pediatric malaria in Africa: act at issue].
    Faucher JF; Missinou MA; Brasseur P
    Med Trop (Mars); 2006 Jun; 66(3):292-4. PubMed ID: 16924825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malaria: an update on current chemotherapy.
    Visser BJ; van Vugt M; Grobusch MP
    Expert Opin Pharmacother; 2014 Oct; 15(15):2219-54. PubMed ID: 25110058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantifying the pharmacology of antimalarial drug combination therapy.
    Hastings IM; Hodel EM; Kay K
    Sci Rep; 2016 Sep; 6():32762. PubMed ID: 27604175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of pregnancy on the pharmacokinetic properties of artemisinin combination therapy (ACT): a systematic review.
    Burger RJ; Visser BJ; Grobusch MP; van Vugt M
    Malar J; 2016 Feb; 15():99. PubMed ID: 26891915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.
    Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D
    Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights following change in drug policy: a descriptive study for antimalarial prescription practices in children of public sector health facilities in Jharkhand state of India.
    Mishra N; Gupta R; Singh S; Rana R; Shahi B; Das MK; Anvikar AR; Valecha N
    J Vector Borne Dis; 2013 Dec; 50(4):271-7. PubMed ID: 24499849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. World Antimalarial Resistance Network (WARN) IV: clinical pharmacology.
    Barnes KI; Lindegardh N; Ogundahunsi O; Olliaro P; Plowe CV; Randrianarivelojosia M; Gbotosho GO; Watkins WM; Sibley CH; White NJ
    Malar J; 2007 Sep; 6():122. PubMed ID: 17822537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simplified antimalarial therapeutic monitoring: using the day-7 drug level?
    White NJ; Stepniewska K; Barnes K; Price RN; Simpson J
    Trends Parasitol; 2008 Apr; 24(4):159-63. PubMed ID: 18353727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.